Fund Evaluator:
Optimize Strategy Index ETF (OPTZ)Equity
Global Asset Class
U.S. Equity
Fund Group
Mid-Cap Blend
Category
$0.000
NAV (as of )
$0.00
Minimum Initial
0.25% B
Expense Ratio
$258 Mil
Assets
Open
Status
0.00%
12b-1 Fee
0.47%
TTM Yield
0.00%
Max Load
130%
Portfolio Turnover
Best Performing in Mid-Cap Blend Over the Last Year
| 67.2% | Paradigm Select (PFSLX) |
| 39.8% | ICON Equity Investor (ISTAX) |
| 32.4% | Fidelity Advisor Mid Cap II Z (FZAMX) |
| 31.5% | Vanguard Strategic Equity Inv (VSEQX) |
| 29.8% | CRM All Cap Value Inv (CRMEX) |
Data as of 7/31/2026
-9.9% F
1-Mo Return
6.9% A
3-Mo Return
24.4% A
YTD Return
40.8% A
1-Yr Return
na
3-Yr Return
na
5-Yr Return
na
Category Risk Index
na
Total Risk Index
Fund Details
Fund Family
Optimize Financial Inc
Inception Date
4/22/2024
Share Class Type
Equity Investment Style
Mid-Cap
Blend
Bond Investment Style
na
Socially Responsible Fund
No
Index Fund
Yes
Benchmark Index
S&P 500 (TR): 100%
Additional Fund Details
Optimize Strategy Index ETF Overview
OPTZ Trailing NAV Total Returns Data as of 7/31/26
| Last Month |
Last Quarter |
Ann'l. 1Yr |
Ann'l. 3Yr |
Ann'l. 5Yr |
Ann'l. 10Yr |
|
| OPTZ Return (NAV) | -9.9% | 6.9% | 40.8% | na | na | na |
| OPTZ Grade | F | A | A | na | na | na |
| +/- Category | -8.0% | 3.1% | 23.0% | na | na | na |
| Mid-Cap Blend Avg | -1.8% | 3.9% | 17.8% | 12.7% | 7.6% | 10.3% |
| OPTZ Tax Cost Ratio | na | na | 0.2% | na | na | na |
OPTZ Annual NAV Total ReturnsData as of 7/31/26
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
| OPTZ Return (NAV) | 24.4% | 22.8% | na | na | na | na | na | na | na | na | na |
| OPTZ Grade | A | A | na | na | na | na | na | na | na | na | na |
| +/- Category | 11.3% | 14.8% | na | na | na | na | na | na | na | na | na |
| Mid-Cap Blend Avg | 13.0% | 7.9% | 13.5% | 16.4% | -15.1% | 24.3% | 13.3% | 28.5% | -10.3% | 16.1% | 14.6% |
| Risk Measures | |
| Standard Deviation: | na |
| Total Risk Index: | na |
| Category Risk Index: | na |
| Category Risk Grade: | |
| Beta: | na |
| R-Squared: | na |
| Leveraged Fund: | No |
| Inverse Fund: | No |
| Portfolio Characteristics | |
| Equity Investment Style: | Mid-Cap Blend |
| Bond Investment Style: | na |
| Yield: | 0.5% |
| Dividend Distribution: | Annually |
| Cap Gains Distribution: | Annually |
| Total Assets: | $258 Mil |
| Fund Total Assets: | $ 259 Mil |
| Share Class Type: | |
| Portfolio Turnover: | 130% |
Management Team
| Number of Managers: 1 | |||
| Longest Tenure: 2.3 years | |||
| Average Tenure: 2.3 years | |||
| Managers (Year): Witters Casey (2024) | |||
Portfolio Composition (as of 7/31/26)
| # of Holdings: | 340 |
| % in Top 10 Holdings: | 22.3% |
| Fund is Non-Diversified: | No |
| % in Foreign Issues: | 3.6% |
Portfolio Allocation |
|
| Domestic Stock: | 95.5% |
| Foreign Stock: | 3.6% |
| Preferred Stock: | 0.1% |
| Domestic Bond: | 0.0% |
| Foreign Bond: | 0.0% |
| Convertible Bond: | 0.0% |
| Other: | -0.0% |
| Cash: | 0.9% |
Purchase Information
| Fund Family: | Optimize Financial Inc |
| Phone Number: | 800-617-0004 |
| Website: |
| Status: | Open |
| Inception Date: | April 22, 2024 |
| Min. Initial Purchase: | $ 0 |
| Min. Initial IRA Purchase: | $ 0 |
| True No-Load: | Yes |
| Front Load Maximum: | 0.00% |
| Deferred Charge Maximum: | 0.00% |
| Redemption Charge Maximum: | 0.00% |
| 12b-1 Fee: | 0.00% |
Expenses and Fees | |
| Expense Ratio (%): | 0.25% ( Rating : Below Avg ) |
| Category Average Expense Ratio (%): | 0.98% |
| Share Class: | Optimize Strategy Index ETF |
| Min. Subsequent Purchase: | $ 0 |
| Min. Subsequent IRA Purchase: | $ 0 |
Copyright 2026 American Association of Individual Investors and Morningstar, Inc. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.